ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Physician Assistant

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,539Medicare Part D Prescriptions Filled, Including Refills

Rank: 16 out of 887

$481K Total Retail Price of All Prescriptions

Rank: 43 out of 887

273 Patients Receiving at Least One Drug in Part D
60%Patients 65 Years and Older
77% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in North Carolina
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 273 patients filled at least one prescription for a schedule two drug, compared to an average of 13%.

Schedule Three
Controlled Substances

32% of this provider’s 273 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

3% of this provider’s 5,718 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 21%.

Prescription Price

$56 was the average price of a prescription from this provider, compared to $72 among peers.

Prescriptions per Patient

31 is the average number of prescriptions (including refills) per patient, compared to an average of 8.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in North Carolina
HYDROCODONE-ACETAMINOPHEN 364 209 S3 1 1
OMEPRAZOLE 314 194 2 2
LISINOPRIL 279 215 3 4
SIMVASTATIN 278 195 4 3
AMLODIPINE BESYLATE 234 163 5 5
METFORMIN HCL 210 126 6 8
TRAMADOL HCL 185 138 7 15
PRAVASTATIN SODIUM 174 127 8 12
GABAPENTIN 167 108 9 6
FUROSEMIDE 163 119 10 7
POTASSIUM CHLORIDE 157 107 11 21
NEXIUM 148 102 12 18
IBUPROFEN 134 71 13 100
NIFEDIPINE ER 118 82 14 168
CARVEDILOL 110 81 15 24
BENAZEPRIL HCL 106 83 16 84
ALLOPURINOL 104 87 17 66
FLUTICASONE PROPIONATE 102 69 18 29
LOSARTAN-HYDROCHLOROTHIAZIDE 99 88 19 68
ATENOLOL 95 63 20 37
METOPROLOL TARTRATE 91 67 21 16
CYCLOBENZAPRINE HCL 91 54 R 21 35
LACTULOSE 91 61 21 201
HYDRALAZINE HCL 88 52 24 139
LEVOTHYROXINE SODIUM 83 59 25 9
METFORMIN HCL ER 82 63 26 50
VENTOLIN HFA 78 31 27 89
PROAIR HFA 77 40 28 39
PREDNISONE 76 37 29 30
ZOLPIDEM TARTRATE 76 47 29 14
LISINOPRIL-HYDROCHLOROTHIAZIDE 76 38 29 22
ADVAIR DISKUS 73 47 32 55
LOSARTAN POTASSIUM 70 54 33 42
DOXAZOSIN MESYLATE 68 57 34 122
AMITRIPTYLINE HCL 68 47 R 34 70
GLIMEPIRIDE 66 31 36 54
CITALOPRAM HBR 63 35 37 23
PANTOPRAZOLE SODIUM 62 44 38 47
MECLIZINE HCL 61 49 39 200
TAMSULOSIN HCL 60 19 40 38
ATORVASTATIN CALCIUM 57 47 41 13
JANUVIA 56 30 42 85
CYMBALTA 53 31 43 40
METOPROLOL SUCCINATE 52 27 44 19
JANUMET 52 40 44 263
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 26, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.